Healthcare WHO agrees global effort to eliminate viral hepatitis by 203... All of the WHO's 194 member states have voted to eliminate viral hepatitis by 2030 as part of a global strategy.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
